Ruiz-Alonso Sandra, Villate-Beitia Ilia, Gallego Idoia, Lafuente-Merchan Markel, Puras Gustavo, Saenz-Del-Burgo Laura, Pedraz José Luis
NanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology. Department of Pharmacy and Food Science, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.
Networking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.
Pharmaceutics. 2021 Feb 26;13(3):308. doi: 10.3390/pharmaceutics13030308.
Three-dimensional (3D) printing is a game changer technology that holds great promise for a wide variety of biomedical applications, including ophthalmology. Through this emerging technique, specific eye tissues can be custom-fabricated in a flexible and automated way, incorporating different cell types and biomaterials in precise anatomical 3D geometries. However, and despite the great progress and possibilities generated in recent years, there are still challenges to overcome that jeopardize its clinical application in regular practice. The main goal of this review is to provide an in-depth understanding of the current status and implementation of 3D bioprinting technology in the ophthalmology field in order to manufacture relevant tissues such as cornea, retina and conjunctiva. Special attention is paid to the description of the most commonly employed bioprinting methods, and the most relevant eye tissue engineering studies performed by 3D bioprinting technology at preclinical level. In addition, other relevant issues related to use of 3D bioprinting for ocular drug delivery, as well as both ethical and regulatory aspects, are analyzed. Through this review, we aim to raise awareness among the research community and report recent advances and future directions in order to apply this advanced therapy in the eye tissue regeneration field.
三维(3D)打印是一项具有变革性的技术,在包括眼科在内的各种生物医学应用中都有着巨大的前景。通过这项新兴技术,可以以灵活且自动化的方式定制特定的眼部组织,将不同的细胞类型和生物材料融入精确的解剖学三维几何结构中。然而,尽管近年来取得了巨大进展并带来了诸多可能性,但仍有一些挑战需要克服,这些挑战危及到其在常规临床实践中的应用。本综述的主要目的是深入了解3D生物打印技术在眼科领域的现状和应用,以便制造诸如角膜、视网膜和结膜等相关组织。特别关注对最常用的生物打印方法的描述,以及3D生物打印技术在临床前水平进行的最相关的眼部组织工程研究。此外,还分析了与3D生物打印用于眼部药物递送相关的其他问题,以及伦理和监管方面的问题。通过本综述,我们旨在提高研究界的认识,并报告最新进展和未来方向,以便将这种先进疗法应用于眼部组织再生领域。